Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 مناظر
• 07/10/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے